Pluristem Therapeutics - Rasio total nilai perusahaan marang pendapatan PLUR

Pluri Inc (PLUR) - logo korporat

The EV/Sales multiple history demonstrates the market valuation of Pluri Inc. (PLUR), where this metric equals 31773.97. Management is currently adapting the cell platform for the agricultural sector and foodtech. A team of experienced bioengineers is developing innovative placenta-based drugs. The technological foundation is provided by Israeli plants featuring autonomous power supplies and strict climate control within clean zones.

PLUR Pluri: Rasio nilai perusahaan marang pendapatan ing interval 23.11.2025 - 20.11.2026

PLUR (pluri-biotech.com): rincian analitis lan laporan miturut indikator

- rega saham lan prakiraan rega para ahli:
Pambiji fundamental:PLUR - Pluri Inc
Produk merek Pluri Inc.

The EV/Sales metric determines the enterprise value of a business, including net debt relative to sales volume, allowing for an assessment of the real value of assets without distortions from leverage. By analyzing current EV/Sales trends, an investor can identify if an asset is overbought, which is critical for Pluri Inc. (PLUR), whose capitalization relies on the patent protection of cell technologies but is limited by commercialization risks in medicine and foodtech.

Analisis pesaing

ASND: Rasio nilai perusahaan marang pendapatan|MDGL: Multiplikator EV/Sales|CORT - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Rhythm Corp|Akero Corp (AKRO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan metsera.com (MTSR)|Nilai perusahaan marang pendapatan moonlaketx.com MLTX|Multiplikator EV/Sales CRNX (Crinetics Pharmaceuticals, Inc.)|NAMS: Rasio nilai perusahaan marang pendapatan|SLNO - Rasio nilai perusahaan marang pendapatan|Amicus Pharma (FOLD) - Nilai perusahaan marang pendapatan|ETNB: Multiplikator EV/Sales|AGIO - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan GPCR|Multiplikator nilai perusahaan marang pendapatan MiMedx MDXG|Rasio nilai perusahaan marang pendapatan Rezolute Corp (RZLT)|Nilai perusahaan marang pendapatan Lexicon Corp LXRX|Rasio nilai perusahaan marang pendapatan MBX Biosciences, Inc. MBX|Multiplikator EV/Sales altimmune.com ALT|AARD - Rasio nilai perusahaan marang pendapatan|Sagimet - Koefisien nilai perusahaan marang pendapatan|BioAge Labs Inc. (BIOA) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang volume dodolan BMEA (Biomea Fusion, Inc.)|QNCX (quincetx.com) - Multiplikator EV/Sales|GUTS: Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan vtvtherapeutics.com (VTVT)|ATPC (Agape ATP) - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan synlogictx.com SYBX|LPCN: Rasio nilai perusahaan marang pendapatan|MTNB - Rasio nilai perusahaan marang pendapatan|Spruce Biosciences, Inc. (SPRB) - Nilai perusahaan marang pendapatan|GLTO: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Carmell Corp. (CTCX)|LUMO (Lumos Therapeutics) - Multiplikator EV/Sales|Organovo Corp (ONVO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Radius Recycling (RDUS)